Optimal cutoff of the hybrid capture II human papillomavirus test for self-collected vaginal, vulvar, and urine specimens in a colposcopy referral population

Journal of Lower Genital Tract Disease

Volumn 8, Issue 1, 2004, Pages 33-37

  Howard, Michelle ^a   Sellors, John ^b   Kaczorowski, Janusz ^a   Lorincz, Attila ^c  

^a MCMASTER UNIVERSITY   (Canada)

^b Prog Appropriate Technol Hlth   (United States)

^c Digene Corporation   (United States)

Author keywords

Cervical intraepithelial neoplasia; Diagnostic techniques; Human papillomavirus; ROC curve

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; ASSAY; BIOPSY; CLINICAL TRIAL; COLPOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PATIENT REFERRAL; SAMPLE; SCREENING TEST; SENSITIVITY AND SPECIFICITY; URINALYSIS; UTERINE CERVIX CARCINOMA IN SITU; VAGINA; VIRUS HYBRID; VIRUS LOAD; VULVA; WART VIRUS;

EID: 0442279130     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1097/00128360-200401000-00008     Document Type: Article

References (28)

1. Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. J Natl Cancer Inst 1995;87:796-802.
2. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
3. Meijer CJL, Rozendaal L, van der Linden JC, Helmerhorst TJM, Voorhorst FJ, Walboomers JMM. Human papilomavirus testing for primary cervical cancer screening. In: Franco E, Monsenego J, eds. New Developments in Cervical Cancer Screening and Prevention. Oxford: Blackwell Science; 1997:338-47.
4. Lorincz AT. Molecular methods for the detection of human papillomavirus infection. Obstet Gynecol Clin North Am 1996;23:707-30.
5. Josefsson AM, Magnusson PKE, Yitalo N, Sørensen P, Qwarforth-Tubbin P, Andersen PK, et al. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: A nested case-control study. Lancet 2000;355:2189-93.
6. Howard M, Sellors J, Kaczorowski J. Optimized cutoff value for the Hybrid Capture II human papillomavirus test to detect cervical intraepithelial neoplasia. Obstet Gynecol 2002;100:972-80.
7. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999;49:33-64.
8. Tisci S, Shen YH, Fife D, Huang J, Goycoolea J, Ma CP, et al. Patient acceptance of self-sampling for human papillomavirus in rural China. J Lower Gen Tract Dis 2003;7:107-16.
9. Sellors JW, Lorincz AT, Mahony JB, Mielzynski I, Lytwyn A, Roth P, et al. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. Can Med Assoc J 2000;163:513-8.
10. Wright TC Jr, Denny L, Kuhn L, Pollack A, Lorincz A. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. J Am Med Assoc 2000;283:81-6.
11. Belinson J, Qiao YL, Pretorius R, Zhang WH, Elson P, Li L, et al. Shanxi Province cervical cancer screening study: A cross-sectional trial of multiple techniques to detect cervical neoplasia. Gynecol Oncol 2001;83:439-44.
12. Chang CC, Tseng CJ, Liu WW, Jain S, Horng SG, Soong YK, et al. Clinical evaluation of a new model of self-obtained method for the assessment of genital human papilloma virus in an underserved population. Chang Gung Med J 2002;10:664-71.
13. Salmeron J, Lazcano-Ponce E, Lorincz A, Hernandez M, Hernandez P, Leyva A, et al. Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico. Cancer Causes Control 2003;14:505-12.
14. Harper DM, Noll WW, Belloni DR, Cole BF. Randomized clinical trial of PCR-determined human papillomavirus detection methods: Self-sampling versus clinician-directed-biological concordance and women's preferences. Am J Obstet Gynecol 2002;186:365-73.
15. Nobbenhuis MAE, Helmerhorst TMJ, van den Brule AJC, Rozendaal L, Jaspars LH, Voorhorst FJ, et al. Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women. J Clin Pathol 2002;55:435-9.
16. Hillemanns P, Krimmig R, Huttermann U, Dannecker C, Thaler CJ. Screening for cervical neoplasia by self-assessment for human papillomavirus DNA. Lancet 1999;354:1970.
17. Morrison EAB, Goldberg GL, Hagan RJ, Kadish AS, Burk RD. Self-administered home cervicovaginal lavage: A novel tool for the clinical-epidemiologic of genital human papillomavirus infections. Am J Obstet Gynecol 1982;167:104-7.
18. Forslund O, Hansson BG, Rymark P, Bjerre B. Human papillomavirus DNA in urine samples compared with that in simultaneously collected urethra and cervix samples. J Clin Microbiol 1993;31:1975-9.
19. Vossler JL, Forbes BA, Adelson MD. Evaluation of the polymerase chain reaction for the detection of human papillomavirus lomavirus from urine. J Med Virol 1995;45:354-60.
20. Brinkman JA, Jones WE, Gaffga AM, Sanders JA, Chaturvedi AK, Slavinsky J III, et al. Detection of human papillomavirus DNA in urine specimens from HIV-positive women. J Clin Microbiol 2002;40:3155-61.
21. Coutlee F, Hankins C, Lapointe N, the Canadian Women's HIV Study Group. Comparison between vaginal tampon and cervicovaginal lavage specimen collection for detection of human papillomavirus DNA by the polymerase chain reaction. J Med Virol 1997;51:42-7.
22. Jacobson DL, Womack SD, Peralta L, Zenilman JM, Feroli D, Maehr J, et al. Concordance of human papillomavirus in the cervix and urine among inner city adolescents. Pediatr Infect Dis J 2000;19:722-8.
23. Sellors JW, Mahony JB, Kaczorowski J, Lytwyn A, Bangura H, Chong S, et al. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Can Med Assoc J 2000;163:503-8.
24. Woodman CBJ, Collins S, Winter H, Bailey A, Ellis J, Previous P, et al. Natural history of cervical human papillomavirus infection in young women: A longitudinal cohort study. Lancet 2001;357:1831-6.
25. Sellors JW, Karwalajtys TL, Kaczorowski J, Mahony JB, Lytwyn A, Chong S, et al. Incidence, clearance and predictors of human papillomavirus infection in women. Can Med Assoc J 2003;168:421-5.
26. Younden JW. Index for rating diagnostic tests. Cancer 1950;2:32-5.
27. Yitalo N, Sørensen P, Josefsson AM, Magnusson PKE, Andersen PK, Pontén J, et al. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: A nested case-control study. Lancet 2000;355:2194-8.
28. Dzuba IG, Diaz EY, Allen B, Leonard YF, Lazcano Ponce EC, Shah KV, et al. The acceptability of self-collected samples for HPV testing vs. the Pap test as alternatives to cervical cancer screening. J Womens Health General Based Med 2002;11:265-75.